Ly-6A/Stem cell antigen-1 (Ly-6A/Sca-1) is a glycosylphosphatidylinositol-anchored protein expressed on many cell types including hematopoietic stem cells (HSCs) and early lymphoid-specific progenitors. Ly-6A/Sca-1 is expressed on CD4 + T cells and plays a role in regulating cellular responses to foreign antigens. The role of Ly-6A/Sca-1 in primary antibody responses has not been defined. To investigate whether Ly-6A/Sca-1 functions in humoral immunity, we first injected Ly-6A/Sca-1-deficient and wild-type control mice with chicken ovalbumin (c-Ova) protein mixed with an adjuvant. We then assessed the ability of the mice to generate a primary antibody response against cOva. We further examined the development of B cells and circulating antibody isotypes in non-immunized Ly-6A/Sca1deficient mice to determine if Ly6A/Sca-1 functions in development irrespective of antigenspecific immune activation. Ly-6A/Sca-1/Sca-1-deficient mice did not show any significant changes in the number of B lymphocytes in the bone marrow and peripheral lymphoid tissues. Interestingly, Ly-6A/Sca-1/Sca-1 -/-mice have significantly elevated serum levels of IgA with λ light chains compared to wild type controls. B cell clusters with high reactivity to anti-IgA λ monoclonal antibody were detected in the lamina propria of the gut, though this was not observed in the bone marrow and peripheral lymphoid tissues. Despite these differences, the Ly-6A/Sca-1deficient mice generated a similar primary antibody response when compared to the wild-type mice. In summary, we conclude that the primary antibody response to cOva antigen is similar in Ly-6A/Sca-1deficient and sufficient mice. In addition, PLOS ONE |
Introduction
Ly-6A/Sca-1 (also known as Stem cell antigen-1 and T cell Activating Protein) is a GPI (Glycosylphosphatidylinositol) anchored protein that belongs to a Ly-6 supergene family [1, 2] . Ly-6 proteins are expressed both in invertebrates and vertebrates [3] [4] [5] [6] . Mouse Ly-6 proteins are markers of differentiation of immune cells and have cell adhesion and cell signaling properties [7] [8] [9] [10] [11] [12] . Ly-6A/Sca-1, is expressed on primary CD4
+ T cells at low levels and is up-regulated during activation [13] [14] [15] . Experiments examining antigen receptor responses of CD4 + T cells lacking expression of Ly-6A/Sca-1 or precociously expressing higher level of this protein indicate its inhibitory role in immune activation [11, 12] . CD4 + T cells lacking the expression of Ly-6A/Sca-1 on the surface show moderately high responsiveness to signaling through the TCR [11] and overexpression of this protein on primary CD4 + T cells results in their reduced responsiveness in response to a model antigen [12] . In addition, primary CD4 + T cells with altered expression of Ly-6A/Sca-1
show a distinct cytokine profile [12] but its role in aiding primary antibody response is unknown. Effector helper T cells play a central role in T-dependent B cell responses that require cognate interaction between effector T cells with antigen-primed B cells [16] . B cells present the antigen to effector helper T cells [16] and a number of co-stimulatory proteins on B cells interact with their cognate ligands on effector T cells leading up to a germinal center reaction and development of generation of memory B cells and plasma cells [17] . Constitutive expression of Ly-6A/Sca-1 on 35% of primary CD4 + T cells and upregulated expression upon activation provides a strong rationale to study primary antibody responses in Ly-6A/Sca-1 deficient mice. High surface expression of Ly-6A/Sca-1 is observed on the earliest hematopoietic progenitors, the hematopoietic stem cells (HSC), which possess self-renewal capacity and the potential to differentiate into every blood lineage [18] . Bone marrow multipotent progenitors (MPPs), which can differentiate into the majority of blood lineages but lack self-renewal potential, also express high levels of Ly-6A/Sca-1 protein in conjunction with c-Kit and flt3 proteins [19] [20] . The common lymphoid progenitors (CLPs), which develop from the MPPs and have a linneg Sca1(Ly-6A) low kit low flt3 pos IL7Ra pos phenotype, are predominantly committed to generating lymphocytes [21] . A body of data suggests that the CLPs are capable of developing into B [22] [23] [24] , T [22, 24, 25] , NK [26] and dendritic cells [23, 27] . While there is an agreement on CLPs for B cell development [28, 29] , a controversy still exists about their role as precursors to T cell development [24, 25] . Other investigators have identified lin neg Sca1(Ly-6A) low kit neg IL7Ra-pos Flt3 pos precursor cells that are distinct from classical CLPs but possess T, B, and NK cell potential [30, 31] . More recently Ly-6D + expressing CLPs exclusively generate B cells [32] . An understanding of the functional role of Ly-6A/Sca-1 in influencing the differentiation of early progenitors, especially in the development of B lymphocytes, is limited. Using the Ly-6A/Sca1deficient mouse model, it was observed that Ly-6A/Sca-1 expression plays a role in efficient production of megakaryocytes and platelets in the bone marrow [33] . Our studies using the Ly-6A/Sca-1 deficient mouse model have shown that regulated expression of Ly-6A/Sca-1on developing T cells is important for T cell development in mice [34] . More importantly, the status of B cell development in Ly-6A/Sca-1 -/-mice is unknown. These experiments were critical for assessing and interpreting our findings that relate to antigen-specific primary antibody responses in Ly-6A/Sca-1deficient mice. We find that B cell development in Ly-6A/Sca-1 deficient mice is not altered. Interestingly, we observed a higher representation of IgA with λ light chain in the blood as well as λ + B cells in the lamina propria of Ly-6A/Sca-1 deficient mice. Regardless of these changes, the primary antibody response to chicken ovalbumin mounted by Ly-6A/Sca-1 deficient and sufficient mice was similar.
Materials and Methods Mice
Ly-6A/Sca-1 knockout mice (a generous gift from Dr. Patrick Flood at University of North Carolina, Chapel Hill) [11] bred on a C57BL/6 background and C57BL/6 wild-type mice (Taconic, Germantown, NY, USA) of both sexes (ages 5-8 weeks) were used for the experiments. Mice were housed and bred at the Villanova University vivarium in accordance with approved IACUC protocols and guidelines. The use of animals was approved by The Villanova Institutional Animal Care committee (IACUC) under protocol "BP05.BIO". 
Media and buffers

Preparation of cells from thymus, bone marrow, spleen, and peritoneum
Thymus, spleen and lymph nodes removed from the mice were deposited into 5 mL of cold wash media and gently ground using frosted ends of glass slides. Bone marrow cells (from the tibia, fibula, femur and humerus) was extracted by repeatedly flushing with 3 mL of cold wash media using a 25 gauge needle attached to a 3 cc syringe (BD Biosciences, East Rutherford, NJ, USA). Samples were centrifuged for 10 minutes at 1000 rpm at 4°C and the supernatant was aspirated. Red blood cells in these cell preparations from spleen and bone marrow were subjected to lysis by incubating the cells in 1.0 mL of hypotonic Tris-NH 4 Cl solution at 37°C for 5 minutes. For harvesting cells from the peritoneal exudates, 10 ml of cold serum-free RPMI 1640 was injected into the peritoneum using 18 gauge needle. The injected medium was withdrawn and deposited into a 15 mL tube on ice and harvested after centrifugation for 10 minutes at 1000 rpm at 4°C. To isolate peyer's patches (PP), female and male Ly6A/Sca-1 -/-and C57Bl/ 6 wild type (control) mice were euthanized with CO 2 asphyxiation. The small intestine was dissected by cutting intestine *0.5 cm below stomach and then holding the intestine at the top with forceps and slowly pulling it out of the peritoneal cavity and incising it *1 cm above cecum. The intestines were pulled gently from the peritoneal cavity, separating unwanted fat and connective tissue. Contents of the intestine were removed by squeezing with 2 pairs of tweezers, gently along the length to expel the contents. Peyer's patches (PPs) were visualized using feces as background. The PPs were removed with fine forceps and scissors by grasping the patches in the tips of the forceps and cutting them off with scissors. Peyer's patches resemble a tiny, single "node", two to eight PPs were found in a small intestine.
Immunizations and serum collection
Chicken ovalbumin was dissolved in phosphate-buffered saline (PBS) at 2 mg/mL concentration and filtered with 0.45μm membrane filter and mixed 1:1 with TiterMax Gold (TiterMax USA, Atlanta, USA). About 4 week old male Ly-6A/Sca-1 -/-or wild-type mice were injected with 100 μL OVA and TiterMax, 100 μL TiterMax alone intraperitoneally. Animals were housed in the animal facility for 21 days post-injection and then euthanized by CO 2 inhalation. Blood was collected via cardiac prick and allowed to coagulate at 4°C. Serum was collected after centrifugation at 1000 rpm for 10 minutes at 4°C. Control normal serum was obtained from un-injected, age and sex-matched mice.
Flow cytometric analyses
After the cells had been prepared, between 500,000 and 1.25 million cells from these single-cell suspensions were incubated with 1 μg of the appropriate primary antibodies (listed below) for 45 minutes on ice, with vortexing at every 7-10 minute intervals. These cells were washed twice with phosphate buffer followed by incubation for 15 minutes with an appropriate second step reagent-conjugated to a fluorochrome. 
Statistics
A two way ANOVA between sex and genotype was performed for each tissue being analyzed as well as each stage of development being analyzed for B and T lymphocytes. Post hoc Tukey's HSD tests were performed on ANOVA to determine the significance of the results. Significant interactions between the genotype, age and sex were determined and reported here.
Results
Unaltered development of B and T cells in Ly-6A/Sca-1 deficient mice
Ly-6A/Sca-1is one of several molecules expressed on HSCs, the early progenitor cells which give rise to all hematopoietic lineages [18] including B lymphocytes. Prior to assessing antibody responses generated in Ly-6A/Sca-1deficient mice in response to cOVA, we examined the development of B cell subsets in the bone marrow and other peripheral immune tissues in the Ly-6A/Sca-1 deficient mice. While examining B cell development in Ly-6A/Sca-1deficient mice we observed that female Ly-6A/Sca-1 -/-mice on a C57BL/6 background showed a 46% decrease in B220 + cells in the bone marrow when compared to female wild-type C57 BL/6 mice (p = 0.0003) (Fig 1a) . This decrease was not observed in male Ly-6A/Sca-1 -/-mice when com- female C57 BL/6 wild-type mice (p = 0.0004 and p = 0.0003 respectively) (Fig 1b) . In contrast, we did not observe differences in these immature subsets of B cells in male Ly-6A/Sca-1 -/-mice when compared to male C57 BL/6 wild-type mice (p = 0.75 and p = 0.71 respectively) (Fig 1b) . We did not observe a difference in the pre/pro B cell populations in males or females of wildtype and Ly-6A/Sca-1deficient mice (pre/pro B cells, female: p = 0.10; male: p = 0.57). Neither did we observe a difference within the mature/re-circulating B cell population between wildtype and Ly-6A/Sca-1deficient females (females, p = 0.78) (Fig 1b) . However, we did observe difference in the mature/re-circulating B cells in the males (males, p = 0.007). While we observed sex-specific differences in the relative representation of developing B cell subsets, the absolute numbers of B cells produced in the bone marrow of Ly-6A/Sca-1 -/-mice was not significantly different from the wild-type (Fig 2) , neither did we find any sex-specific differences as well (Fig 2) . Furthermore, the absolute number within each of the developmental subset was not significantly different from the wild-type mice of the same gender (Fig 2) . Analysis of the B cell compartments in the spleen and lymph nodes of Ly-6A/Sca-1 -/-demonstrated unaltered representation of B cells when compare to Ly-6A/Sca-1 sufficient mice (S2 Fig) and numbers in spleen (data not shown). Taken together our data show that B cell development in male and female Ly-6A/Sca-1 deficient mice is similar to age and sex-matched wildtype littermates. However, we do observe sex-specific alterations in the percentage of B cells in the marrow of female Ly-6A/Sca-1 deficient mice that are likely cell non-autonomous. We examined the expression of B220 and CD5 proteins to enumerate the B-1 and B-2 cells from the retrieved peritoneal exudates (PEC) from the wild-type and Ly-6A/Sca-1 Knockout mice [35] . Live lymphoid population were gated (S3 Fig) for enumeration Primary antibody response to chicken ovalbumin in Ly-6A/Sca-1 deficient mice
To investigate the effects of Ly-6A/Sca-1expression on functional primary B cell responses, female Ly-6A/Sca-1 -/-and wild-type mice were each injected with 100 μg of chicken ovalbumin (cOVA) protein antigen mixed with adjuvant TitreMax, or with adjuvant alone as a control. The serum of injected animals was tested for the presence of anti-OVA antibodies of various isotypes using ELISA. Ly-6A/Sca-1 -/-and wild-type mice injected with the adjuvant, TiterMax alone failed to generate anti-OVA IgG1 antibodies as expected (Fig 3) . In contrast, anti-OVA IgG1 antibodies were generated at comparable levels in Ly-6A/Sca-1 -/-and wild-type mice that received c-OVA along with the TiterMax adjuvant. Kruskal-Wallis analysis of the data indicated no significant difference between adjuvant-alone injected control groups, and cOVA injected groups. In contrast to IgG1, we were either unable to detect (IgG2a isotype) or detect at low levels (IgA isotypes) other isotypes of anti-cOVA antibodies in cOVA antigen with adjuvant or adjuvant-alone injected wild-type mice (Fig 3) . However, we observed the presence of higher levels of anti-OVA IgA antibodies in the serum from Ly-6A/Sca-1 -/-than the wild-type mice injected with cOVA antigen and adjuvant (Fig 3) . Surprisingly, Ly-6A/Sca-1 -/-mice injected with cOVA with adjuvant had comparable levels of anti-OVA IgA antibodies as compared to those injected with adjuvant alone. These data suggest non-specific binding of IgA antibodies from Ly-6A/Sca-1 -/-mice to cOVA coated ELISA plates. This non-specificity was significantly lower when serum from wild-type littermate controls was used (Fig 3) . KruskalWallis analysis indicated that within each genotype there was no difference between adjuvant injected controls and cOVA with adjuvant injected groups. Taken together, our data suggests that primary antibody responses generated in Ly-6A/Sca-1 -/-mice are not significantly different from those generated in wild-type control mice. In addition, we detected higher levels of IgA in Ly-6A/Sca-1 -/-mice injected with adjuvant alone, with non-specific binding property.
Elevated IgA λ levels in Ly-6A/Sca-1 knockout mice
High non-specific binding of IgA antibodies in cOVA with adjuvant or adjuvant alone injected Ly-6A/Sca-1mice was intriguing and therefore prompted us to examine the basal levels of all the isotypes in Ly-6A/Sca-1 -/-and wild-type mice. We used cytometric bead array (CBA) to examine the basal levels of serum immunoglobulin in Ly-6A/Sca-1 -/-mice. While both the wild-type and Ly-6A/Sca-1 -/-knockout animals had high levels of serum IgM, Ly-6A/Sca-1 knockout animals had significantly higher levels of serum IgA λ than their wild-type control littermates (Fig 4) . IgM, IgG 1 , IgG 2a , IgG 3 , and IgE κ and λ chains, as well as IgA κ and IgG2b λ isotypes were not significantly altered in the Ly-6A/Sca-1deficient mice when compared to the littermate controls (Fig 4) .
Unaltered receptor editing in B cells from Ly-6A/Sca-1 -/-mice
Developing B cells in the bone marrow show high representation of λ light chain due to a process known as "receptor editing" [36, 37] . Higher level of serum IgA λ detected in the Ly-6A/ Sca-1deficient mice than the wild-type littermates (Fig 4) was surprising. Therefore, we determined the immunoglobulin light chain usage in developing and mature B cells present in the bone marrow and peripheral lymphoid tissues of Ly-6A/Sca-1deficient mice (Fig 5, Table 2 and S5 Fig) . Similar κ and λ light chain usage was detected in Ly-6A/Sca-1 -/-mice as the wildtype littermates (Fig 5) . However, the absolute numbers of λ and κ expressing IgA + , or IgD + or B220 + B cells in peyer's patch (PP) of Ly-6A/Sca-1 -/-mice appeared to be reduced when compared to the wildtype control mice, the significant differences were only observed in IgA + λ + (p = 0.002) and [38, 39] . Cytokines secreted by helper T cells are known to contribute to this "helping function" [40] . Ly-6A/Sca-1 is constitutively expressed on 35% of primary CD4 + T cells and its expression is up-regulated >100 fold upon activation of CD4 + T cells [7] . Contribution of Ly-6A/Sca-1expression on CD4 + T cells to primary antibody response to a foreign antigen is not known. Our findings suggest that the upregulated expression of Ly-6A/Sca-1does not contribute to primary antibody responses in vivo (Fig 4) . To our surprise the Ly-6A/Sca-1 -/-mice show altered expression of λ light chain in LP of gut associated lymphoid tissue (Fig 6) . T-dependent B cell responses can be viewed to occur in three distinct phases (reviewed in [17] ). The first phase involves generation of effector helper T cells expressing CD40L, other regulatory proteins and chemokine receptors. The second phase involves cognate interaction between effector T cells with antigen-primed B cells. This phase involves trafficking of antigen- The first and second phase of T-dependent B cell response occurs within 7 days of antigen exposure whereas the third phase memory B cells and plasma cells are generated 7 days after antigen exposure [17] . Ly-6A/Sca-1 expressed on primary CD4 + T cells at low levels and activated T cell at higher levels can potentially contribute to B cell responses at different phases of B cell response. Diminished secondary antibody responses to an antigen KLH were reported in Ly-6A/Sca-1 deficient mice [11] . How Ly-6A/Sca-1 contributes to secondary antibody response after antigen challenge and insignificantly participates in the primary antibody response remains unclear. It is formally possible that early expression of Ly-6A/Sca-1 on the first round of activated CD4 + population after primary immunization is not optimal in generating effector/long-lasting plasma cells during the primary antibody response. We speculate that a higher in vivo expression of Ly-6A/Sca-1 on CD4 + T cells, which is achieved after re-challenge with the antigen, is required for generating a long lasting plasma/memory cell population and/or their survival/trafficking to bone marrow and higher antibody responses. Ly-6A/Sca-1and other Ly-6 genes possess interferon-responsive elements [15] and expression of Ly-6A/Sca-1 on activated CD4 + T cells is driven by the action of interferon-γ [14] . The source of interferon-γ and pharmacokinetics of this cytokine required to drive in vivo expression of Ly-6A/Sca-1 remains unknown, but it is higher after antigen challenge than during the primary exposure with the antigen. This is consistent with the idea that naïve CD4 + T cells generate relatively less interferon-γ cytokine than the effector and memory T cells [41, 42] . Alternatively, it remains possible that, early on, the role of Ly-6A/Sca-1 is redundant and substituted by another Ly-6 family member. Ly-6C, another member of the Ly-6 family, is reported to have a role in B cell responses. CD4 + T cells with high expression of Ly-6C express distinct repertoire of TCRs that promote plasma cell production [43] . Additional work will be required to address the role of Ly-6A/Sca-1 in secondary/memory cell responses, our observations provide an impetus to examine the role of Ly-6A/Sca-Ly-6A/Sca-1 expression during differentiation phases of Tdependent B cell responses and antibody generation. In addition to its expression on naïve and activated T cells, Ly-6A/Sca-1 shows expression on progenitor cells and its differentiated states [1, 2] . While Ly-6A/Sca-1 deficiency results in diminished development of megakaryocytes [33] , its role of Ly-6A/Sca-1 in the development of B and T cell lineages has not been fully described. Given the expression of Ly-6A/Sca-1 on HSCs as well as on early lymphoid progenitors that give rise to B and T lymphocytes it was important to study the effects of Ly-6A/Sca-1 on the development of the lymphoid compartment. Ly-6A/Sca-1 deficient mice neither show significantly altered numbers of B-1a, B1b subsets in the peritoneum nor exhibit effects on development of mature follicular B cells in the bone marrow, spleen and lymph nodes (Table 1 ). In addition, Ly-6A/Sca-1 deficient and sufficient mice show similar development of T cells in the thymus. While the absolute number of B cell and T cell subsets in the Ly-6A/Sca-1 deficient and Ly-6A/Sca-1 sufficient mice were similar (Fig 2) , we did observe altered representation (percentages) of B-2 cell subsets in the peritoneum and developing B cells in the bone marrow. Some of these differences were sexspecific. While female C57BL/6 wild-type mice have a higher representation of B220 + cells in the bone marrow than male wild-type mice, the female C57BL/6 mice with a deficiency in the Ly-6A/Sca-1gene show significantly diminished representation of B220 + cells in the bone marrow as compared to Ly-6A/Sca-1 sufficient control mice of the same sex and strain. The developing B cells of female Ly-6A/Sca-1 deficient mice have a similar profile to that of male mice, both wild-type and Ly-6A/Sca-1 -/- (Fig 1) . Taken together these findings suggest that Ly-6A/ Sca-1 does not influence development of B cells. Previous report on Ly-6A/Sca-1 null mice show subtle differences in total numbers and percentages of CFUs for some lineages which were deemed statistically insignificant [11, 33] but sex-specific differences were not evaluated in these reports. Sex-specific altered proportions of B cell subsets that we have observed in the bone marrow suggest that Ly-6A/Sca-1 influences development of yet unknown immune cell population within the lymphoid population, identity which will requires further investigation. Future investigations will also require to fully examine the normal expression of Ly-6A/Sca-1 on CLPs and other progenitors and how its absence alters their numbers and quality in either of the sexes.
Regardless of the genotype, we observed that female mice showed distinct representation of B cells (Fig 1) . Published reports show that hormones in itself or in combination with sexlinked gene products affect B cell development in the bone marrow and the development of T cells in the thymus [44] [45] . Precursors of immune cells, as well as their progeny, express receptors for sex-specific steroid hormones at different development stages [46] . Androgens affect B cell development through androgen receptors expressed on bone marrow stromal cells [47] , and while estrogens can exert their effects by signaling through intracellular estrogen receptors expressed in B and T cells [44, 45, 48] . Moreover, there is a considerable published studies suggesting that males and female mice mount distinct immune responses to self and foreign antigens and that these differences may be crucial to a sex-bias observed during a severe infection [48] and autoimmunity [49] .
We examined the T cell development in Ly-6A/Sca-1 -/-mice starting from the CD44 [34] . Our data is consistent with a previous investigation using these mice where Ly-6A/ Sca-1 deficient mice were reported to have normal development of TCRαβ, TCRγδ, CD4 + , CD8 + T cells [11] . Data presented here extends these studies to both the sexes and also focuses on early developmental stages where Ly-6A/Sca-1 expression is normal expressed. More importantly normal development of CD4 + T cells in Ly-6A/Sca-1 deficient mice implies that primary immune response to a foreign protein, cOvalbumin is not influenced by the numbers of CD4 + T cells in these mice when compared to the wild-type controls.
Interestingly, Ly-6A/Sca-1 deficient mice exhibited unusually higher representation of λ light chain than the wild-type littermates when their serum and LP was examined. Higher representation of λ light chain was exclusively observed in association with α heavy chain and not with μ, γ1, γ2a, γ2b, ε heavy chains in the serum. To investigate the source of circulating IgA with λ light chain prompted us to examine the expression of λ light chain on developing B lymphocytes in the bone marrow and in secondary lymphoid tissues. To examine the mechanism we speculated that this high natural circulating IgA λ may be derived from B cells undergoing excessive receptor editing, where switch from κ to λ light chain occurs in the bone marrow to generate a new B cell receptor to potentially avoid self-reactivity [36, 37] . Contrary to this notion, representation of κ and λ light chains expressed on developing and mature B cells in the bone marrow lymph nodes and peyer's patch of Ly-6A/Sca-1 deficient mice was unaltered and therefore ruling out the contribution of Ly-6A/Sca-1 in the process of receptor editing during B cell selection in the bone marrow. In addition, by using immuno-histological techniques we were able to observe high frequency of λ light chain expression in the lamina propria of Ly-6A/Sca-1 deficient mice. However, higher expression of λ light chain from B cell clusters detected by immunohistochemistry suggests that Ly-6A/Sca-1 expression in the lamina propria influence light chain usage. While previous investigations have revealed that lamina propria has high number of IgA producing plasma cells with hallmarks of IgA switch recombination [50, 51] , the mechanism underlying preferential usage of λ light chain by IgA + B cells is not known. One possible mechanism may involve CD4 + T cells and cytokines they produce in driving this process. Previous reports show altered proliferation and cytokine profile in primary CD4 + T cells with altered expression of Ly-6A [12] . Additionally, other investigators have reported the effects of Ly-6A expression on signaling through TGF-βR1/II [52] and effect of TGF-β on suppressing the expression of Ly-6A (Sca-1) [53] on non-lymphoid cells. These published data provide a possible mechanistic framework for future experiments that we hope will examine a direct or indirect influence of Ly-6A expression on immunoglobulin light chain usage in the gut. Alternate possible mechanism may involve contribution of non-CD4 + T cells (dendritic or epithelial cells) and gut flora in this process. LYPD8, another member of Ly-6 supergene family is known to bind component of gut flora to prevent their proximity to the barrier surface in the gut [54] . Absence of Ly-6A/Sca-1 may provide an altered microenvironment conducive for either the self of gut microflora antigens to exert influence on B cells. Factors that influence light chain switching in LP are unknown and to our knowledge this is the first example where higher representation of λ light chain is reported in LP molecular mechanism of which requires future investigation.
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